NRGN: Neurogranin – A Key Postsynaptic Protein in Cognitive Function and Neurodegeneration

Comprehensive biomedical resource for NRGN (neurogranin), including genomic annotation, expression, mutations, and disease associations.

Gene Information Card

Symbol NRGN
Full Name Neurogranin
Gene Type protein-coding
Chromosomal Location 11q24.2
NCBI Gene ID 4900 ncbi.nlm.nih.gov/gene/4900
Ensembl ID ENSG00000154146
UniProt ID Q92686
OMIM ID 602350
HGNC ID 8000
Aliases RC3, Ng, hng

Description

NRGN (neurogranin) is a protein-coding gene located on chromosome 11q24.2. It encodes a postsynaptic calmodulin-binding protein that plays a critical role in synaptic plasticity, learning, and memory by regulating calmodulin availability and calcium signaling. Neurogranin is predominantly expressed in the brain, especially in the cerebral cortex, hippocampus, and striatum. Altered expression and mutations in NRGN have been associated with Alzheimer's disease, schizophrenia, and other cognitive disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Alzheimer's disease Reduced neurogranin levels impair synaptic plasticity and calcium signaling, contributing to cognitive decline. Cerebrospinal fluid neurogranin is a biomarker for synaptic degeneration. ClinVar, PMID: 25779938
Schizophrenia Genetic variants in NRGN (e.g., rs12807809) are associated with increased risk, possibly through altered dendritic spine density and glutamatergic signaling. OMIM, PMID: 18431406
Bipolar disorder NRGN expression changes in prefrontal cortex may affect mood regulation via calmodulin-dependent pathways. PMID: 22006018

Expression Profile

Tissue Expression
Tissue nTPM level
Cerebral cortex 48.2 High
Hippocampus 42.1 High
Caudate nucleus 35.6 High
Cerebellum 12.3 Medium
Testis 0.8 Low
Liver 0.1 Not detected
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (neuroblastoma) 15.4 Neuronal model, high expression
U-87 MG (glioblastoma) 8.2 Moderate expression
HEK293 (embryonic kidney) 0.3 Very low, non-neuronal
HepG2 (hepatocellular carcinoma) 0.1 Not detected
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
rs12807809 SNP (intronic) 0.33 (European) Associated with schizophrenia risk; may affect splicing or expression
c.197C>T (p.Pro66Leu) Missense <0.01 Rare variant; potential impact on calmodulin binding
c.88G>A (p.Ala30Thr) Missense <0.01 Unknown functional effect; reported in ClinVar
Mutation functional classification

Loss of Function (LOF)

Reduced neurogranin expression or impaired calmodulin binding leads to disrupted synaptic plasticity and cognitive deficits.

Gain of Function (GOF)

Not well characterized; no known gain-of-function mutations reported.

Dominant Negative (DN)

No dominant-negative mutations described for NRGN.

Pathways

Calmodulin signaling pathway
Long-term potentiation (LTP)
Glutamatergic synapse
Alzheimer's disease pathway

Protein Summary

Neurogranin is a 78-amino-acid, 7.6 kDa postsynaptic protein that binds calmodulin in a calcium-dependent manner. It is a substrate for protein kinase C and is involved in the regulation of calcium/calmodulin-dependent signaling, which is essential for long-term potentiation and memory formation. Neurogranin is highly expressed in forebrain regions and is a well-established cerebrospinal fluid biomarker for synaptic dysfunction in Alzheimer's disease.

Related Products

Product name Cat.No. Species Gene ID
NRGN Knockout HEK293 Cell Line EDJ-KQ5362 Human 4900 Details Get a Quote
NRGN Knockout A-549 Cell Line EDJ-KQ28475 Human 4900 Details Get a Quote
NRGN Knockout HCT 116 Cell Line EDJ-KQ28476 Human 4900 Details Get a Quote
NRGN Knockout HeLa Cell Line EDJ-KQ28477 Human 4900 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: